Nabota®

Nabota® is a high-purity botulinum toxin type A developed by Daewoong Pharmaceutical, a leading South Korean biopharmaceutical company known for its innovation and global quality standards. Engineered with advanced purification and manufacturing processes, Nabota® is designed for both aesthetic and therapeutic applications, offering precise neuromodulation with fast onset and long-lasting results.

Produced in a state-of-the-art cGMP-compliant facility, Nabota® boasts one of the highest purity profiles among botulinum toxin products on the market, minimizing the risk of resistance and adverse reactions. It is widely used to treat dynamic wrinkles such as glabellar lines, forehead lines, and crow’s feet, while also being approved in several regions for medical indications including cervical dystonia, blepharospasm, and spasticity.

Recognized internationally, Nabota® has gained approvals in major markets including the United States (as Jeuveau®), Europe, and Asia, reinforcing its reputation for safety, efficacy, and global compliance.

Key Highlights:

  • Botulinum Toxin Type A with exceptional purity

  • Fast-acting and long-lasting results

  • Versatile use in both aesthetic and medical treatments

  • Manufactured by Daewoong Pharmaceutical using advanced biotechnological standards

  • Approved by regulatory authorities worldwide, including the U.S. FDA and EMA

Nabota® by Daewoong represents a new generation of botulinum toxin products—offering reliable, predictable, and natural-looking results trusted by professionals globally.